New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

May 2015

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015

Press Releases / By

CRANBURY, N.J., May 13, 2015 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its third quarter ended March 31, 2015.  Recent Highlights Launched reconnectstudy.com in support of our Bremelanotide Phase 3 …

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015 Read More »

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2015 Results

Press Releases / By

CRANBURY, N.J., May 8, 2015 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2015 operating results on Wednesday, May 13, 2015 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May …

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2015 Results Read More »

Scroll to Top